Abstract
Plant-derived natural products have been an important source of several clinically useful anti-cancer agents. Plants continue to play a major role in drug discovery as evidenced by the number of promising new agents in clinical development based on selective activity against cancer-related molecular targets. Due to improvements in tumor targeting technology, some agents which failed in earlier clinical studies are also stimulating renewed interest. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are possibly produced by endophytic fungi and microbes residing in the plant tissues. We consider that this area of natural product research should be expanded significantly.
Keywords: Plant-derived natural products, anticancer, antitumor, targeted agents, endophytes, Natural Products, Anticancer Drug, cancer-related molecular targets, natural product drugs, endophytic fungi, taxanes, camptothecins, bioactive compounds, semi-synthetic, synthetic analogs, tumor cells, competitive inhibition, Vinca Alkaloids, vinorelbine, cancers, leukemias, lymphomas, breast and lung cancers, Kaposi's sarcoma, Epi-Podophyllotoxins, podophyllotoxin, etoposide, teniposide, colorectal cancers, Plant-derived Clinical Agents, homoharringtonine (HHT), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), complete hematologic remission (CHR), elliptinium (Celiptium), Combretastatins, combretistatin A4 phosphate (CA4), flavopriidol (Alvocidib), rohitukine, olomucine, roscovitine, purvalanol A purvalanol B, Ingenol-3-Angelate, Triptolide, maytansine, Bruceantin, Indirubins, 6-bromoindirubin, 6-bromoindirubin oxime, Silvestrol, epi-Silvestrol, withacnistin A, Emericellamide A
Current Organic Chemistry
Title: Plant Natural Products in Anticancer Drug Discovery
Volume: 14 Issue: 16
Author(s): Paul G. Grothaus, Gordon M. Cragg and David J. Newman
Affiliation:
Keywords: Plant-derived natural products, anticancer, antitumor, targeted agents, endophytes, Natural Products, Anticancer Drug, cancer-related molecular targets, natural product drugs, endophytic fungi, taxanes, camptothecins, bioactive compounds, semi-synthetic, synthetic analogs, tumor cells, competitive inhibition, Vinca Alkaloids, vinorelbine, cancers, leukemias, lymphomas, breast and lung cancers, Kaposi's sarcoma, Epi-Podophyllotoxins, podophyllotoxin, etoposide, teniposide, colorectal cancers, Plant-derived Clinical Agents, homoharringtonine (HHT), acute myelogenous leukemia (AML), chronic myelogenous leukemia (CML), complete hematologic remission (CHR), elliptinium (Celiptium), Combretastatins, combretistatin A4 phosphate (CA4), flavopriidol (Alvocidib), rohitukine, olomucine, roscovitine, purvalanol A purvalanol B, Ingenol-3-Angelate, Triptolide, maytansine, Bruceantin, Indirubins, 6-bromoindirubin, 6-bromoindirubin oxime, Silvestrol, epi-Silvestrol, withacnistin A, Emericellamide A
Abstract: Plant-derived natural products have been an important source of several clinically useful anti-cancer agents. Plants continue to play a major role in drug discovery as evidenced by the number of promising new agents in clinical development based on selective activity against cancer-related molecular targets. Due to improvements in tumor targeting technology, some agents which failed in earlier clinical studies are also stimulating renewed interest. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are possibly produced by endophytic fungi and microbes residing in the plant tissues. We consider that this area of natural product research should be expanded significantly.
Export Options
About this article
Cite this article as:
G. Grothaus Paul, M. Cragg Gordon and J. Newman David, Plant Natural Products in Anticancer Drug Discovery, Current Organic Chemistry 2010; 14 (16) . https://dx.doi.org/10.2174/138527210792927708
DOI https://dx.doi.org/10.2174/138527210792927708 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Small Heat Shock Proteins and the Endoplasmic Reticulum: Potential Attractive Therapeutic Targets?
Current Molecular Medicine Patented Aptamers for C-Reactive Protein Detection: A Review About their Use in Clinical Diagnostics
Recent Patents on DNA & Gene Sequences Review of the Contribution of Radiolabelled Tracers for Tumour Cell Status Imaging
Current Medical Imaging Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets Epigenetic Alterations of the Wnt/β -Catenin Pathway in Human Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Androgen Receptor Cofactors in Prostate Cancer: Potential Therapeutic Targets of Castration-Resistant Prostate Cancer
Current Cancer Drug Targets The Pim Kinases: New Targets for Drug Development
Current Drug Targets Cancer Stem Cell Markers in Nasopharyngeal Carcinoma and Its Relevance for Therapy
Current Traditional Medicine Prediction and Analysis of Hepatocellular Carcinoma Related Genes Using Gene Ontology and KEGG
Current Bioinformatics Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
Current Pharmaceutical Design Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma
Current Drug Targets The Woman’s Heart: Insights into New Potential Targeted Therapy
Current Medicinal Chemistry The Radionuclide Molecular Imaging and Therapy of Neuroendocrine Tumors
Current Cancer Drug Targets Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy
Current Drug Targets Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression – the Concept of Committed Progenitor Cells
Current Cancer Drug Targets Predictive Biomarkers and Novel Targets in the Treatment of Metastatic Renal Cell Carcinoma
Current Medicinal Chemistry Mitochondrial DNA Mutations in Cancer: A Review
Current Topics in Medicinal Chemistry The Therapeutic Potential of Small Activating RNAs for Colorectal Carcinoma
Current Gene Therapy Carbonic Anhydrase Inhibitors and the Management of Cancer
Current Topics in Medicinal Chemistry The “Gene Cube”: A Novel Approach to Three-dimensional Clustering of Gene Expression Data
Current Bioinformatics